4.8 Article

Physical Rehabilitation for Older Patients Hospitalized for Heart Failure

期刊

NEW ENGLAND JOURNAL OF MEDICINE
卷 385, 期 3, 页码 203-216

出版社

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMoa2026141

关键词

-

资金

  1. National Institutes of Health [R01AG045551, R01AG18915, P30AG021332, P30AG028716, U24AG059624]
  2. Oristano Family Fund at Wake Forest School of Medicine

向作者/读者索取更多资源

In a diverse population of older patients who were hospitalized for acute decompensated heart failure, an early, transitional, tailored, progressive rehabilitation intervention that included multiple physical-function domains resulted in greater improvement in physical function than usual care.
BACKGROUND Older patients who are hospitalized for acute decompensated heart failure have high rates of physical frailty, poor quality of life, delayed recovery, and frequent rehospitalizations. Interventions to address physical frailty in this population are not well established. METHODS We conducted a multicenter, randomized, controlled trial to evaluate a transitional, tailored, progressive rehabilitation intervention that included four physical-function domains (strength, balance, mobility, and endurance). The intervention was initiated during, or early after, hospitalization for heart failure and was continued after discharge for 36 outpatient sessions. The primary outcome was the score on the Short Physical Performance Battery (total scores range from 0 to 12, with lower scores indicating more severe physical dysfunction) at 3 months. The secondary outcome was the 6-month rate of rehospitalization for any cause. RESULTS A total of 349 patients underwent randomization; 175 were assigned to the rehabilitation intervention and 174 to usual care (control). At baseline, patients in each group had markedly impaired physical function, and 97% were frail or prefrail; the mean number of coexisting conditions was five in each group. Patient retention in the intervention group was 82%, and adherence to the intervention sessions was 67%. After adjustment for baseline Short Physical Performance Battery score and other baseline characteristics, the least-squares mean (+/- SE) score on the Short Physical Performance Battery at 3 months was 8.3 +/- 0.2 in the intervention group and 6.9 +/- 0.2 in the control group (mean between-group difference, 1.5; 95% confidence interval [CI], 0.9 to 2.0; P<0.001). At 6 months, the rates of rehospitalization for any cause were 1.18 in the intervention group and 1.28 in the control group (rate ratio, 0.93; 95% CI, 0.66 to 1.19). There were 21 deaths (15 from cardiovascular causes) in the intervention group and 16 deaths (8 from cardiovascular causes) in the control group. The rates of death from any cause were 0.13 and 0.10, respectively (rate ratio, 1.17; 95% CI, 0.61 to 2.27). CONCLUSIONS In a diverse population of older patients who were hospitalized for acute decompensated heart failure, an early, transitional, tailored, progressive rehabilitation intervention that included multiple physical-function domains resulted in greater improvement in physical function than usual care.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Longitudinal Changes in Cardiac Troponin and Risk of Heart Failure Among Black Adults

Amit Saha, Kershaw Patel, Colby Ayers, Christie M. Ballantyne, Adolfo Correa, Christopher Defilippi, Michael E. Hall, Robert J. Mentz, Stephen L. Seliger, Wondwosen Yimer, Javed Butler, Jarett D. Berry, James A. De Lemos, Ambarish Pandey

Summary: Among Black adults, persistent or worsening levels of cardiac troponin I (hs-cTnI) are associated with an increased risk of heart failure (HF). Participants with incident, stable or improved, or worsened hs-cTnI elevation had higher HF risk compared to those without elevated hs-cTnI.

JOURNAL OF CARDIAC FAILURE (2023)

Review Cardiac & Cardiovascular Systems

Do PRO Measures Function the Same Way for all Individuals With Heart Failure?

Theresa M. Coles, L. Lin, Kevin Weinfurt, Bryce B. Reeve, John A. Spertus, Robert J. Mentz, Ileana L. Pin, Fraser d. Bocell, Michelle e. Tarver, Debra m. Henke, Anindita Saha, Brittany Caldwell, Silver Spring

Summary: Women diagnosed with heart failure report worse quality of life than men on PRO measures. The assumption that women and men interpret quality of life questions the same way is crucial for valid comparison and combining outcomes by subgroups in heart failure. This issue not only affects clinical trials, but also has important implications for addressing health inequities. The validity of PRO measures is key to interpreting differences in heart failure outcomes.

JOURNAL OF CARDIAC FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Frailty and Effects of a Multidomain Physical Rehabilitation Intervention Among Older Patients Hospitalized for Acute Heart Failure A Secondary Analysis of a Randomized Clinical Trial

Ambarish Pandey, Dalane W. W. Kitzman, M. Benjamin Nelson, Amy M. M. Pastva, Pamela Duncan, David J. J. Whellan, Robert J. J. Mentz, Haiying Chen, Bharathi Upadhya, Gordon R. R. Reeves

Summary: Frailty is common among older patients with ADHF and is associated with worse QOL and higher risk of clinical events. The REHAB-HF trial showed that a 3-month tailored physical rehabilitation intervention improved physical function and QOL for these patients. This analysis found that patients with worse baseline frailty had a more significant improvement in physical function with the intervention compared to those who were prefrail.

JAMA CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial

Stephen J. Greene, Eric J. Velazquez, Kevin M. Anstrom, Robert A. Clare, Tracy A. DeWald, Mitchell P. Psotka, Andrew R. Ambrosy, Gerin J. Stevens, John Rommel, Tamas Alexy, Fassil Ketema, Dong-Yun Kim, Patrice Desvigne-Nickens, Bertram L. Pitt, Eric J. Eisenstein, Robert Mentz, TRANSFORM-HF Investigators

Summary: The TRANSFORM-HF trial compared the effects of torsemide and furosemide on patient-reported outcomes among patients with heart failure. The study found that there was no significant difference in improving symptoms or quality of life between torsemide and furosemide over a period of 12 months.

CIRCULATION (2023)

Article Cardiac & Cardiovascular Systems

Echocardiographic Features Beyond Ejection Fraction and Associated Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Anthony E. Peters, Robert M. Clare, Karen Chiswell, G. Michael Felker, Anita Kelsey, Robert Mentz, Adam D. DeVore

Summary: Heart failure guidelines recommend assessment of left ventricular ejection fraction (LVEF) to classify patients. However, LVEF alone may be insufficient to characterize patients with mildly reduced or preserved LVEF. Recommendations on additional testing are lacking, and there are limited data on use of echocardiographic features beyond LVEF in these patients.

CIRCULATION-HEART FAILURE (2023)

Review Cardiac & Cardiovascular Systems

Continuous Monitoring of Heart Rate Variability and Clinical Outcomes in Patients with Implantable Cardioverter Defibrillators

Anthony E. Peters, Angie Wu, Karen Chiswell, Paul Hofmann, Richard Nkulikiyinka, Wilfried Dinh, Jonathan P. Piccini, Robert J. Mentz, Marat Fudim

Summary: Continuous monitoring of heart rate variability (HRV) in 225 patients with cardiac defibrillators or cardiac resynchronization devices showed modest changes over a 2-year period. Low baseline HRV, indicative of low parasympathetic tone and/or increased sympathetic tone, was associated with worse clinical outcomes in terms of all-cause hospitalization. However, changes in HRV observed over a 6-month follow-up period did not predict subsequent outcomes.

CURRENT PROBLEMS IN CARDIOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Lifting and Healing as We Climb: Women's Heart Month

Ersilia M. Defilippis, Robert J. Mentz, Anuradha Lala

JOURNAL OF CARDIAC FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event

Robert J. Mentz, Jonathan H. Ward, Adrian F. Hernandez, Serge Lepage, David A. Morrow, Samiha Sarwat, Kavita Sharma, Scott D. Solomon, Randall C. Starling, Eric J. Velazquez, Kristin Williamson, Shelley Zieroth, Eugene Braunwald

Summary: The PARAGON-HF trial evaluated the effects of Sac/Val compared to Val on clinical outcomes in patients with HFpEF or HFmrEF. The PARAGLIDE-HF trial further investigated the use of Sac/Val in patients with recent worsening HF events and in specific populations not well represented in the PARAGON-HF trial, including those with de novo HF, severe obesity, and Black patients.

JOURNAL OF CARDIAC FAILURE (2023)

Review Cardiac & Cardiovascular Systems

Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society

Hiroyuki Tsutsui, Nancy M. Albert, Andrew J. S. Coats, Stefan D. Anker, Antoni Bayes-Genis, Javed Butler, Ovidiu Chioncel, Christopher R. Defilippi, Mark H. Drazner, G. Michael Felker, Gerasimos Filippatos, Mona Fiuzat, Tomomi Ide, James L. Januzzi Jr, Koichiro Kinugawa, Koichiro Kuwahara, Yuya Matsue, Robertj Mentz, Marco Metra, Ambarish Pandey, Giuseppe Rosano, Yoshihiko Saito, Yasushi Sakata, Naoki Sato, Petar M. Seferovic, John Teerlink, Kazuhiro Yamamoto, Michihiro Yoshimura

Summary: Natriuretic peptides, brain (B-type) natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP), are important markers for the diagnosis and risk stratification of heart failure (HF). This article is the result of a collaboration among three heart failure societies and provides a comprehensive perspective on the use of natriuretic peptides in the diagnosis and management of HF.

JOURNAL OF CARDIAC FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Impact of Diabetes and Hypertension on Left Ventricular Structure and Function: The Jackson Heart Study

Arsalan Hamid, Wondwosen K. Yimer, Adebamike A. Oshunbade, Daisuke Kamimura III, Donald Clark, Ervin R. Fox, Yuan- Min, Paul Muntner, Daichi Shimbo, Ambarish Pandey, Amil M. Shah, Robert J. Mentz, Daniel W. Jones, Alain G. Bertoni, John E. Hall, Adolfo Correa, Javed Butler, Michael E. Hall

Summary: This study aimed to assess the independent effects of diabetes and hypertension on left ventricular (LV) remodeling in Black adults. Through a cross-sectional analysis of Black adults, it was found that diabetes was only associated with changes in LV structure and function when accompanied by hypertension. These findings suggest that hypertension is the main contributor to cardiac structural and functional changes in Black adults with diabetes.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Nursing

An interprofessional initiative to improve the drop to shock interval on a college campus

Margory A. Molloy, Margaret Bowers, Amy M. Pastva, Jacqueline Vaughn

Summary: This project engaged healthcare students in a creative interprofessional activity to solve a healthcare problem by designing a program to increase awareness of automated external defibrillators device locations on campus. Engaging students in such interdisciplinary projects promotes skills, teamwork, and communication that are essential for their future careers in healthcare.

TEACHING AND LEARNING IN NURSING (2023)

Article Cardiac & Cardiovascular Systems

Relationship of Race With Functional and Clinical Outcomes With the REHAB-HF Multidomain Physical Rehabilitation Intervention for Older Patients With Acute Heart Failure

Olivia N. Gilbert, Robert J. Mentz, Alain G. Bertoni, Dalane W. Kitzman, David J. Whellan, Gordon R. Reeves, Pamela W. Duncan, Michael Benjamin Nelson, Vanessa Blumer, Haiying Chen, Shelby D. Reed, Bharathi Upadhya, Christopher M. O'Connor, Amy M. Pastva

Summary: This study found that a 3-month rehabilitation intervention improved physical function and health-related quality of life in both older Black and White patients with acute decompensated heart failure, without significant differences between the two racial groups. However, the association between intervention and reduced all-cause rehospitalizations was stronger in White patients compared to Black patients, suggesting the need for further research.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Editorial Material Cardiac & Cardiovascular Systems

Noncardiac Comorbidities in Chronic Heart Failure: More Is Worse, What Else Do We Know?

Robert J. Mentz, Veraprapas Kittipibul, Anita Deswal

JACC-HEART FAILURE (2023)

暂无数据